Dillion Naslund was a 25 year old veteran having served with the 133rd Regiment and served in Iraq for 4 years and had just come from a 1 year Middle East deployment. Just like other parents, the Naslunds were happy to have their son back home and he also seemed to enjoy being back and sharing time with family and friends. Things soon fell apart with Dillion suffering depression and was eventually diagnosed with PTSD after his family took him to the Veteran Affairs, a stress disorder common among combat returnees, in Dillions case, treatment seemed to have worked, but in hindsight, the Naslunds believe he just got better at hiding his situation from the family, Dillion sent a text to his ex-girlfriend on December 10th who alerted his parents, he was later found dead, he had committed suicide.
Following their son’s death, the Naslunds realized many more families were dealing with situations similar to theirs, the Veteran Affairs says roughly 20 veterans commit suicide daily, about 1 death every hour. This statistic is what buoyed the Naslunds to start Engage America, an organization that helps bring together veterans ,their families and friends by offering support programs such as health (mental and medical), education (check more on their website http://www.operationengageamerica.org/) and also help connect them to other veteran care organizations.
If you know any returned veteran who might need their help, or any veteran, you might refer them and have them get help and gun down PTSD.
The problems connected to post-traumatic stress disorder (PTSD) have been connected to military veterans seemingly forever, though the actual designation has seen an evolution over that time frame. Much of the medical attention toward this issue over the past few generations have been directed at finding ways to reduce, if not eliminate the problem. That’s because of the very real dangers that can often lead to those veterans taking their own lives.
Legislation in New York that coincided with Veterans Day celebrations is in the process of being finalized that will allow veterans suffering from PTSD to use medical marijuana to treat their problem. Currently, 28 states have already included the disorder within the medical treatment programs that have been established, a number that’s effectively been doubled in just the past three years.
Much of the recent push has been driven by groups that represent veterans’ interests, including the American Legion. While there’s been no definitive studies to show that PTSD can deliver effective results, countless anecdotal cases have shown that the anxiety that many veterans have felt upon their return home has been reduced by having access to medical marijuana.
The inclusion of the American Legion when it comes to the concept’s vocal advocates may seem to be strange to some observers, considering that the organization has long been seen as one that possesses strong conservative roots. However, the organization agreed to lobby for greater use when members specifically noted the aid they had been receiving from such usage.
A former Marine whose military experiences left him with post-traumatic stress disorder, commonly abbreviated as PTSD, is undergoing a clinical trial that has thus far shown a lot of promise for other veterans who suffer from this condition.
Mark Bratton served in Iraq and Afghanistan from 2007 to 2009; he was later diagnosed with PTSD and was forced to endure depression, anxiety and neurotic behavior. More than 2.5 million veterans suffer from PTSD, and most of them are prescribed medications such as Zoloft and Paxil, which were modeled after the successful Prozac came on the market to treat symptoms patients who suffer from depression.
In Bratton’s case, a service dog and a sublingual trial medication that contains a muscle relaxant have been very effective in terms of containing his PTSD symptoms. The medication is currently in its third stage of clinical trials in Texas, and has not yet been named.
According to television news station KGW, an NBC affiliate in Portland, the medication does not go directly into the bloodstream and does not present the typical side effects of drowsiness. Although the current trials feature veterans as test subjects, the medication will also be helpful to civilians whose PTSD symptoms are triggered by emotionally traumatic experiences.
The Food and Drug Administration has placed the trial medication into a fast-track phase for the purpose of making it available as soon as possible. This acceleration of trials is only granted to medications that show lots of promise and a high level of confidence in their effectiveness.